D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.41% |
| 2 | Technology | 9.4% |
| 3 | Healthcare | 8.95% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
CALL
Fair Isaac
FICO
$29.8B
| $908K | ﹤0.01% |
10,000
| – | – |
|
|
2752
PUT
Fair Isaac
FICO
$29.8B
| $908K | ﹤0.01% |
+10,000
| New | +$897K |
|
2753
CALL
Truist Financial
TFC
$63.9B
| $907K | ﹤0.01% |
22,500
| – | – |
|
|
BPMC
2754
DELISTED
Blueprint Medicines
BPMC
| $906K | ﹤0.01% |
+34,191
| New | +$976K |
|
2755
CBIZ
CBZ
$2.37B
| $905K | ﹤0.01% |
93,845
-1,216
| -1% | -$11.4K |
|
|
SSRG
2756
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $905K | ﹤0.01% |
103,783
-3,422
| -3% | -$28.2K |
|
2757
Antero Resources
AR
$10.6B
| $898K | ﹤0.01% |
26,157
-8,041
| -24% | -$319K |
|
2758
PUT
HSBC
HSBC
$355B
| $896K | ﹤0.01% |
+22,447
| New | +$935K |
|
2759
Huazhu Hotels Group
HTHT
$12.9B
| $895K | ﹤0.01% |
+146,548
| New | +$883K |
|
2760
Novartis
NVS
$300B
| $893K | ﹤0.01% |
10,132
-3,260
| -24% | -$299K |
|
2761
Descartes Systems
DSGX
$6.12B
| $891K | ﹤0.01% |
55,500
-15,100
| -21% | -$234K |
|
2762
iShares Russell 2000 ETF
IWM
$80.1B
| $890K | ﹤0.01% |
7,126
+2,000
| +39% | +$250K |
|
|
DNR
2763
PUT
DELISTED
Denbury Resources, Inc.
DNR
| $890K | ﹤0.01% |
140,000
-90,000
| -39% | -$686K |
|
2764
Digi International
DGII
$2.47B
| $889K | ﹤0.01% |
93,109
+24,285
| +35% | +$237K |
|
|
BDSI
2765
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $888K | ﹤0.01% |
111,561
+88,350
| +381% | +$759K |
|
2766
Kinder Morgan
KMI
$70.8B
| $885K | ﹤0.01% |
+23,039
| New | +$962K |
|
|
LHO
2767
DELISTED
LaSalle Hotel Properties
LHO
| $885K | ﹤0.01% |
24,944
-20,722
| -45% | -$765K |
|
|
LTXB
2768
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $884K | ﹤0.01% |
+29,258
| New | +$768K |
|
2769
Aon
AON
$78.9B
| $881K | ﹤0.01% |
8,835
-172,031
| -95% | -$17.2M |
|
2770
Sun Communities
SUI
$15.1B
| $881K | ﹤0.01% |
+14,248
| New | +$903K |
|
2771
Inovio Pharmaceuticals
INO
$81.1M
| $879K | ﹤0.01% |
8,979
+232
| +3% | +$24.8K |
|
|
NOR
2772
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $878K | ﹤0.01% |
147,514
+45,540
| +45% | +$730K |
|
|
CTXS
2773
PUT
DELISTED
Citrix Systems Inc
CTXS
| $877K | ﹤0.01% |
15,698
+3,140
| +25% | +$167K |
|
|
STI
2774
DELISTED
SunTrust Banks, Inc.
STI
| $877K | ﹤0.01% |
+20,379
| New | +$866K |
|
|
RPRX
2775
DELISTED
Repros Therapeutics Inc.
RPRX
| $877K | ﹤0.01% |
122,723
+56,142
| +84% | +$437K |
|
Similar funds
D.E. Shaw & Co's Q2 2015 Portfolio in Review
As of Q2 2015, D.E. Shaw & Co held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co's Q2 2015 filing shows 504 new, 1,541 increased, 1,228 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.
- D.E. Shaw & Co's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- D.E. Shaw & Co added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- D.E. Shaw & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- D.E. Shaw & Co fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- D.E. Shaw & Co opened 504 new positions and closed 364 in Q2 2015.
- D.E. Shaw & Co's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.